DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer. (2015)
Attributed to:
Predictive biomarkers of response to DNA repair targeting agents in sporadic prostate cancer
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1056/nejmoa1506859
PubMed Identifier: 26510020
Publication URI: http://europepmc.org/abstract/MED/26510020
Type: Journal Article/Review
Volume: 373
Parent Publication: The New England journal of medicine
Issue: 18
ISSN: 0028-4793